• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Hospital Readmissions Reduction Program and COPD: More Answers, More Questions.医院再入院减少计划与慢性阻塞性肺疾病：更多答案，更多问题。
J Hosp Med. 2020 Apr 1;15(4):252-253. doi: 10.12788/jhm.3362. Epub 2020 Feb 11.
2
The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015.医院再入院率降低计划与慢性阻塞性肺疾病的再入院情况，2006 - 2015年
Ann Am Thorac Soc. 2020 Apr;17(4):450-456. doi: 10.1513/AnnalsATS.201909-672OC.
3
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.2009 年至 2014 年佛罗里达州慢性阻塞性肺疾病（COPD）患者再入院率、住院费用和死亡率趋势。
Clin Ther. 2018 Apr;40(4):613-626.e1. doi: 10.1016/j.clinthera.2018.03.006. Epub 2018 Mar 31.
4
Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.降低慢性阻塞性肺疾病的住院再入院率。美国胸科学会官方专题研讨会报告。
Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.
5
Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices.慢性阻塞性肺疾病的合并症与 30 天内住院再入院几率：Charlson 和 Elixhauser 合并症指数的比较。
BMC Health Serv Res. 2019 Oct 15;19(1):701. doi: 10.1186/s12913-019-4549-4.
6
Chronic Obstructive Pulmonary Disease Readmissions and Other Measures of Hospital Quality.慢性阻塞性肺疾病再入院情况及医院质量的其他衡量指标
Am J Respir Crit Care Med. 2017 Jul 1;196(1):47-55. doi: 10.1164/rccm.201609-1944OC.
7
Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.实施医院再入院率降低计划后，对慢性阻塞性肺疾病再入院的经济影响的洞察。
Curr Opin Pulm Med. 2018 Mar;24(2):138-146. doi: 10.1097/MCP.0000000000000454.
8
Exploring Novel Medicare Readmission Risk Variables in Chronic Obstructive Pulmonary Disease Patients at High Risk of Readmission within 30 Days of Hospital Discharge.探索慢性阻塞性肺疾病患者中 30 天内再入院高风险患者的新型医疗保险再入院风险变量。
Ann Am Thorac Soc. 2015 Sep;12(9):1288-93. doi: 10.1513/AnnalsATS.201504-228OC.
9
Evaluation of prediction strategy and care coordination for COPD readmissions.慢性阻塞性肺疾病再入院的预测策略与护理协调评估
Hosp Pract (1995). 2016 Aug;44(3):123-8. doi: 10.1080/21548331.2016.1210472. Epub 2016 Jul 19.
10
Chronic Rhinitis Is a High-Risk Comorbidity for 30-Day Hospital Readmission of Patients with Asthma and Chronic Obstructive Pulmonary Disease.慢性鼻炎是哮喘和慢性阻塞性肺疾病患者 30 天内住院再入院的高风险合并症。
J Allergy Clin Immunol Pract. 2019 Jan;7(1):279-285.e6. doi: 10.1016/j.jaip.2018.06.029. Epub 2018 Jul 25.

引用本文的文献

1
Effectiveness of a Bundled Payments for Care Improvement Program for Chronic Obstructive Pulmonary Disease.基于按病种付费的慢性阻塞性肺疾病医疗照护改善计划的效果。
J Gen Intern Med. 2023 Sep;38(12):2662-2670. doi: 10.1007/s11606-023-08249-6. Epub 2023 Jun 20.
2
Preventing COPD Readmissions Under the Hospital Readmissions Reduction Program: How Far Have We Come?在医院再入院率降低计划下预防 COPD 再入院：我们已经走了多远？
Chest. 2021 Mar;159(3):996-1006. doi: 10.1016/j.chest.2020.10.008. Epub 2020 Oct 14.
3
Readmission Rates for Chronic Obstructive Pulmonary Disease Under the Hospital Readmissions Reduction Program: an Interrupted Time Series Analysis.住院患者再入院率降低计划下的慢性阻塞性肺疾病再入院率：一项中断时间序列分析。
J Gen Intern Med. 2020 Dec;35(12):3581-3590. doi: 10.1007/s11606-020-05958-0. Epub 2020 Jun 17.

本文引用的文献

1
Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重后不同再入院诊断的相关因素
J Hosp Med. 2020 Apr 1;15(4):219-227. doi: 10.12788/jhm.3367. Epub 2020 Feb 11.
2
Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.降低慢性阻塞性肺疾病的住院再入院率。美国胸科学会官方专题研讨会报告。
Ann Am Thorac Soc. 2019 Feb;16(2):161-170. doi: 10.1513/AnnalsATS.201811-755WS.
3
Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.医院再入院率降低计划与医疗保险受益人因心力衰竭、急性心肌梗死和肺炎住院的死亡率之间的关联。
JAMA. 2018 Dec 25;320(24):2542-2552. doi: 10.1001/jama.2018.19232.
4
Exploring Novel Medicare Readmission Risk Variables in Chronic Obstructive Pulmonary Disease Patients at High Risk of Readmission within 30 Days of Hospital Discharge.探索慢性阻塞性肺疾病患者中 30 天内再入院高风险患者的新型医疗保险再入院风险变量。
Ann Am Thorac Soc. 2015 Sep;12(9):1288-93. doi: 10.1513/AnnalsATS.201504-228OC.
5
Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion.了解慢性阻塞性肺疾病（COPD）患者再次入院的原因：一项大型全国性研究，以划定纳入再入院处罚扩大范围的医疗保险人群。
Chest. 2015 May;147(5):1219-1226. doi: 10.1378/chest.14-2181.
6
Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.40至64岁因慢性阻塞性肺疾病住院患者早期再入院的预测因素。
Ann Am Thorac Soc. 2014 Jun;11(5):685-94. doi: 10.1513/AnnalsATS.201310-358OC.
7
The complexity of disease combinations in the Medicare population.医疗保险人群中疾病组合的复杂性。
Popul Health Manag. 2011 Aug;14(4):161-6. doi: 10.1089/pop.2010.0044. Epub 2011 Jan 17.
8
Rehospitalizations among patients in the Medicare fee-for-service program.医疗保险按服务收费项目参保患者的再次住院情况。
N Engl J Med. 2009 Apr 2;360(14):1418-28. doi: 10.1056/NEJMsa0803563.

The Hospital Readmissions Reduction Program and COPD: More Answers, More Questions.

作者信息

Press Valerie G, Miller Brian J

机构信息

Department of Medicine, University of Chicago Medicine, Chicago, Illinois.

Department of Medicine, MedStar Georgetown University Hospital, Washington, DC.

出版信息

J Hosp Med. 2020 Apr 1;15(4):252-253. doi: 10.12788/jhm.3362. Epub 2020 Feb 11.

DOI:10.12788/jhm.3362
PMID:32118570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7153487/
Abstract
摘要